{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:55:59Z","timestamp":1777949759452,"version":"3.51.4"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Central nervous system (CNS) relapse in acute lymphoblastic leukemia (ALL) may occur despite systemic remission and can present with isolated neuro-ophthalmologic symptoms. Early diagnosis may be challenging as the initial neuroimaging and ophthalmologic evaluation can be non-diagnostic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation\/discussion<\/jats:title>\n                    <jats:p>\n                      We report on a 57-year-old man with Philadelphia chromosome-positive (\n                      <jats:italic>Ph<\/jats:italic>\n                      +) B-cell ALL in remission on dasatinib maintenance therapy who presented with acute vision and hearing loss. The initial evaluation, including magnetic resonance imaging (MRI) and ophthalmologic examination, did not reveal a definitive etiology, and drug-induced toxicity was initially considered. However, cerebrospinal fluid (CSF) analysis demonstrated lymphoblasts, establishing the diagnosis of CNS relapse. Repeat imaging later revealed leptomeningeal and optic nerve sheath enhancement consistent with disease progression. The patient was treated with intrathecal chemotherapy, with subsequent clearance of CSF blasts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights delayed recognition of CNS relapse due to initial diagnostic anchoring and underscores the limitations of early imaging in detecting CNS involvement. CSF analysis remains the most sensitive diagnostic modality and should be pursued early in patients with ALL who present with unexplained visual or neurologic symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1758791","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:25:23Z","timestamp":1777868723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: An interesting case of vision and hearing loss revealing CNS recurrence in Philadelphia-positive acute lymphoblastic leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Ifeoma","family":"Ike","sequence":"first","affiliation":[{"name":"Internal Medicine, Eisenhower Health","place":["Rancho Mirage, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor M.","family":"Samperio","sequence":"additional","affiliation":[{"name":"Internal Medicine, Eisenhower Health","place":["Rancho Mirage, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry T.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Lucy Curci Cancer Center, Eisenhower Health","place":["Rancho Mirage, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update - PubMed","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1122714","article-title":"Case report: First report of isolated central nervous system lymphoblastic crisis in a child with chronic myeloid leukemia on dasatinib therapy - PubMed","volume":"13","author":"Jo","year":"2023","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1097\/WNO.0000000000001365","article-title":"Leukemic and lymphomatous optic neuropathy: a case series","volume":"41","author":"Lee","year":"2021","journal-title":"J Neuro-Ophthalmol"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24862","article-title":"Adult acute lymphoblastic leukemia: concepts and strategies - PubMed","volume":"116","author":"Faderl","year":"2010","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1080\/01658107.2020.1714667","article-title":"Neuro-ophthalmology illustrated, 3rd edition: by val\u00e9rie biousse and nancy J. Newman, new york, NY, thieme medical publishers, inc. 2020, 696 pp. 662 illustrations, 69 video clips, $119.99 (softcover), ISBN: 9781684200740, (e-book) ISBN: 9781684200757","volume":"44","author":"Bellows","year":"2020","journal-title":"Neuro-Ophthalmology"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.4103\/IJO.IJO_159_23","article-title":"Anti-MOG antibody optic neuritis in AML \u2013 A case report","volume":"3","author":"Barigali","year":"2023","journal-title":"Indian J Ophthalmol - Case Rep"},{"key":"B7","article-title":"Dasatinib - pubmed","volume":"39","author":"Korashy","year":"2014","journal-title":"Profiles Drug Substances Excipients Related Method"},{"key":"B8","article-title":"Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case","volume":"29","author":"Monge","year":"2015","journal-title":"Saudi J Ophthalmol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(00)00563-5","article-title":"Hearing loss due to acute leukemia - PubMed","volume":"109","author":"Kurtz","year":"2000","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy - PubMed","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retinal Eye Res"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.66.11.2","article-title":"Clinical manifestations and ophthalmic outcomes of leukemic retinopathy and optic neuropathy in patients with acute leukemia","volume":"66","author":"Chen","year":"2025","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B12","article-title":"Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy","volume":"29","author":"Miller","year":"2014","journal-title":"Eye"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29646","article-title":"Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia - PubMed","volume":"121","author":"Ravandi","year":"2015","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2405573","article-title":"Ph-Positive acute lymphoblastic leukemia - 25 years of progress - PubMed","volume":"392","author":"Fo\u00e0","year":"2025","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2022.2398","article-title":"Treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-from intensive chemotherapy combinations to chemotherapy-free regimens: a review - PubMed","volume":"8","author":"Jabbour","year":"2022","journal-title":"JAMA Oncol"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104806","article-title":"Comparison of third-generation tyrosine kinase inhibitor (TKI) ponatinib with first- and second-generation TKIs for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a systematic review and bias-corrected meta-analysis - PubMed","volume":"213","author":"Raza","year":"2025","journal-title":"Crit Rev Oncology\/Hematol"},{"key":"B17","article-title":"Acute lymphoblastic leukemia relapse presenting with optic nerve infiltration - PubMed","volume":"11","author":"Dini","year":"2023","journal-title":"SAGE Open Med Case Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1758791\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:25:26Z","timestamp":1777868726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1758791\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":17,"alternative-id":["10.3389\/fonc.2026.1758791"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1758791","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1758791"}}